PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
26-Oct-2023 Envirotainer supports Canadian biopharmaceutical distribution Envirotainer
26-Oct-2023 Endogena Therapeutics Secures FDA Green Light for Breakthrough AMD Treatment Endogena Therapeutics
26-Oct-2023 Astraveus awarded €10.4 million grant by the French government as part of France 2030 investment plan Astraveus
26-Oct-2023 Almirall opens new call for proposals to better understand key pathological mechanisms of several skin diseases Almirall
26-Oct-2023 CPHI Pharma Award Winners 2023 CPHI Barcelona
26-Oct-2023 Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2023 (IFRS) Takeda Pharmaceutical Company Limited
25-Oct-2023 Secarna Pharmaceuticals presents data at OTS showcasing unique characteristics and factors with a role in the activity and side effect profile of LNA-modified ASOs Secarna Pharmaceuticals GmbH & Co. KG
25-Oct-2023 Velocity aggressively expands MASH/MASLD capabilities with latest site acquisitions Velocity Clinical Research
25-Oct-2023 Gilead Sciences ranked by Newsweek as a one of the UK’s ‘Most Loved Workplaces of 2023’ Gilead Sciences
25-Oct-2023 Liebherr presents its innovative cooling solutions at Lab Innovations 2023 Liebherr
25-Oct-2023 myNEO evolves into myNEO Therapeutics to reflect its new strategy to develop off-the-shelf cancer vaccine immunotherapeutics myNEO
25-Oct-2023 Scientists raise £2m for 3D human lung model to replace animal testing ImmuONE
25-Oct-2023 Nykode Therapeutics ASA - Private Placement Completed Nykode Therapeutics ASA
25-Oct-2023 Cantourage Group SE: NuWays confirms 'Buy' recommendation Cantourage Group SE
25-Oct-2023 MorphoSys Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023 MorphoSys AG
25-Oct-2023 Ad hoc: MorphoSys AG Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023 MorphoSys AG
25-Oct-2023 DEFENCE’S ACCUTOX® AND ANTIGEN CROSS-PRESENTATION: DISCOVERY LEADS TOWARDS THE DEVELOPMENT OF A GROUDNBREAKING PLATFORM Defence Therapeutics Inc.
24-Oct-2023 Abivax announces Closing of its Initial Public Offering on the Nasdaq Global Market ABIVAX
24-Oct-2023 Newly established 3PARL® consortium to assure global life sciences industry of consistent high standard of GMP supply chain audits Rephine
24-Oct-2023 Medios AG: Strong operating cash flow – record figures as expected also for revenue and earnings in the third quarter of 2023 Medios AG